Certificate Number,Certificate
DE_HE_01_GMP_2019_0226,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: nasal spray(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
UK API 28255 Insp GMP 28255/123039-0012,
UK MIA 28255 Insp GMP 28255/123039-0012,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.4  Other: Manufacture API's(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK MIA 39307 Insp GMP/GDP 39307/303632-0041,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
UK ManA 28255 Insp GMP 28255/123039-0012,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.17  Other: Traditional Herbal products(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.4  Other: Hopguard, Liquid topical ectoparasitic for bees (minor use, minor species)(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical"
VMDGMP/M081/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.15  Intraruminal devices 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.15  Intraruminal devices 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
19MPP074HPT01,
DE_BW_01_GMP_2020_0062,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2019_0235,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HH_01_GMP_2020_0010,
IT/E/API/1/2020,
IT/E/API/2/2020,
IT/GMP/E/7/2019,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Aseptic blending of powders(en) Special Requirements               : 1  B-lactam Antibiotics 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
NL/H 19/2015836,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.1.17  Other: Granules for oral suspension(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: Granules for oral suspension(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/29500-2/2021,
OGYÉI/45080-6/2019,
UK GMP 32874 Insp GMP 32874/444644-0006,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA(IMP) 25076 Insp IMP 25076/331469-0012,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.4  Impregnated matrices 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.9  Pressurised preparations 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.14  Transdermal patches 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
sukls209782/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: nasal spray(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: nasal spray(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0234,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2019_0256,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2020_0005,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK GMP 31047 Insp GMP/IMP 31047/343945-0014 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.1.4  Biological
UK GMP 31047 Insp GMP/IMP 31047/343945-0014 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.1.4  Biological
UK MIA 11311 Insp GMP/GDP 11311/16282866-0005,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK MIA 41013 Insp GMP 41013/12691111-0004,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK MIA 4351 Insp GMP/IMP 4351/15302-0030,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.5  Liquids for external use Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.11  Semi-solids Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.12  Suppositories Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.13  Tablets Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.17  Other: Filling of Powders(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.5  Liquids for external use Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.11  Semi-solids Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.12  Suppositories Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.13  Tablets Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.17  Other non-sterile medicinal products: Filling of powders(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
UK MIA(IMP) 11412 Insp GMP/IMP 11412/4348964-0002,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Human Serum(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.3  Cell therapy products 1.3.1.8  Other: Tissue engineered products(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA(IMP) 13101 Insp IMP 13101/21095-0008,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.1.6  Other: Formulation/Reconstitution of biologicals and peptide hormones with subsequent manufacture of small(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.17  Other: Radiolabelled substances e.g. liquids, solid dosage forms and capsules(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Packaging of immunological and biotechnology products. Packaging of human or animal extracted produc(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Radiolabelled substances e.g. e.g. liquid and solid dosage forms.(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.4  Impregnated matrices 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation"
UK MIA(IMP) 4351 Insp GMP/IMP 4351/15302-0030,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.5  Liquids for external use Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.11  Semi-solids Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.12  Suppositories Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.13  Tablets Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.17  Other: Capsules Hard Shell - encapsulation of cytotoxic tablets, Filling of Powders.(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.5  Liquids for external use Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.11  Semi-solids Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.12  Suppositories Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.13  Tablets Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.17  Other non-sterile medicinal products: Filling of powders. Capsule hard shells encapsulation of cytotoxic tablets(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
UK ManA 4351 Insp GMP/IMP 4351/15302-0030,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.5  Liquids for external use Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.11  Semi-solids Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.1.13  Tablets Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.5  Liquids for external use Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.11  Semi-solids Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.1.13  Tablets Special Requirements               : 7  Other: Inclusion of Potent, Toxic Compounds(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
19MPP084HPT01,
UK MIA 18024 Insp GMP/IMP 18024/10321-0017,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.3  Other importation activities 2.3.1  Site of physical importation
UK MIA(IMP) 18024 Insp GMP/IMP 18024/10321-0017,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.17  Other: Oro-mucosal sprays.(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation"
VMDGMP/T082/2019,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
DE_HE_01_GMP_2019_0205,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2019_0253,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK API 29350 Insp GMP 29350/6523-0009 [H],
UK API 8931 Insp GMP 8931/646098-0006 [H],
UK API 8931 Insp GMP 8931/646098-0006 [V],
UK MIA 14704 Insp GMP 14704/5493-0016,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical"
UK MIA 29498 Insp GMP 29498/13540451-0002,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK MIA 43461 Insp GMP 43461/18810009-0001,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK ManA 14704 Insp GMP 14704/5493-0016,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical"
UK ManA 29498 Insp GMP 29498/13540451-0002,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK GMP 22775 Insp GMP/IMP 22775/31008-0006 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility
UK GMP 22775 Insp GMP/IMP 22775/31008-0006 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility
UK MIA 1175 Insp GMP 1175/2404-0019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.17  Other: Solid non-sterile multi-dose forms (including powders and granules) Pillules(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.17  Other non-sterile medicinal products: Solid non-sterile multi-dose forms (including powders and granules) Pillules(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.4  Other: homeopathic and herbal medicines(en)
OGYÉI/47056-6/2019,
19MPP083HPT01,
BE/GMP/2019/067,
FT043/SA/001/2020,
DE_BY_04_GMP_2020_0066,
DE_HE_01_GMP_2019_0204,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2019_0255,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
FT078/MH/001/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: Sachets(en) 1.2.1.13  Tablets 1.2.1.17  Other: Granules and pellets for further processing(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: Sachets(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
MT/028HM/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0252,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2021_0107,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
DE_SH_01_GMP_2020_0001,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Surgident Gingival Retraction cord No. 1  Surgident Gingival Retraction cord No. 2  Surgident Gingival Retraction cord No. 3  Surgident Gingival Retraction cord No. 4(en)
Insp GMP 31201/349094-0009 NCR,"1 NON-COMPLIANT MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.1.17  Other: Dry Powder for Oral Suspension(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Dry Powder for Oral Suspension(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK GMP 31201 Insp GMP 31201/349094-0009,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.1.17  Other: Dry Powder for Oral Suspension(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Beta - Lactum Products(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility"
UK MIA 30619 Insp GMP/GDP 30619/13757321-0006,2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
UK MIA(IMP) 25224 Insp IMP 25224/89442-0012,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.8  Other: Recombinant Proteins(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.8  Other: Recombinant Proteins(en)
VMDGMP/M076/2019,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Biological(en)
DE_HE_01_GMP_2019_0250,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK GMP 20003 Insp GMP 20003/117007-0011,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
VMDGMP/M078/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
UK GMP 42546 Insp GMP 42546/14193-0009,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.4  Impregnated matrices 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.4  Impregnated matrices 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
UK GMP 44139 Insp GMP 20752/13875-0013,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.2.5  Other: Emulsions(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 44403 Insp GMP/IMP 44403/13167-0027,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.3.1.8  Other: Botulinum Toxins and Toxoids Bacterial Enzymes (Erwinia L-asparaginase) Bacterial Toxoids(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_BY_05_GMP_2020_0019,
482722-0002,
DE_HE_01_GMP_2019_0208,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
UK GMP 15967 Insp GMP/IMP 15967/7364-0007 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.1.4  Biological
UK GMP 15967 Insp GMP/IMP 15967/7364-0007 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.1.4  Biological
UK GMP 2915 Insp GMP/IMP 2915/36834-0008 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological
UK GMP 2915 Insp GMP/IMP 2915/36834-0008 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological
19MPP073HPT01,
DE_HE_01_GMP_2020_0007,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
482689-0003,
DE_BY_05_GMP_2021_0024,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.17  Other: Pellets containing active substances(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.17  Other non-sterile medicinal products: Pellets containing active substances (Bulk)(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2019_0183,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2020_0006,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA 44400 Insp GMP 44400/15007630-0005,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: Cytotoxics, Cytostatics and controlled drugs(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 735 Insp GMP 735/17567-0013,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
CH20-0133,
DE_HE_01_GMP_2019_0182,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA 45175 Insp GMP 45175/12862135-0003,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
111/2019/GMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
482592-0003,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0188,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2019_0192,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
IWPS.405.107.2019.KK.1 WTC/0597_01_01/250,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK GMP 17742 Insp GMP 17742/11082-0014,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0193,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
VMDGMP/M077/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
UK API 30812 Insp GMP 30812/16026-0001,
UK MIA(IMP) 21439 Insp IMP 21439/18803335-0003,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Radiopharmaceuticals for injection(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 22481 Insp GMP 22481/366976-0005,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.1.17  Other: Oral powder for reconstruction(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
FT059/MH/001/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK API 10762 Insp GMP 10762/1649-0005,
13-Jun,
IWSF.405.8.2020.KK.1 WTC/0567_01_02/16,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: manufacture of sterile active substance (Cefazolin Sodium Sterile, Cefotaxime Sodium Sterile, Ceftazidime Pentahydrate with Sodium Carbonate for Injection Sterile, Ceftriaxone Sodium Sterile)(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
OGYÉI/33402-6/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Manufacture of pellets(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Manufacture of pellets(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA(IMP) 43280 Insp IMP 43280/10139174-0004,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation"
2020/HPF/PT/004,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IT/E/API/04/2020,
IT/E/API/04/2020 rev.1,
OGYÉI/36774-5/2019,
VMDGMP/M071/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
VMDGMP/M080/2019,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
ES/160HV/19*,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
ES/160HV/19*/1,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK GMP 19756 Insp GMP 19756/12912665-0003,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Sterile ophthalmic solutions and Otic solutions.(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.2.5  Other: Small volume Parenteral (SVP)(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 39716 Insp GMP 39716/3187772-0006,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
25709,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Preparation and storage of mammalian and bacterial working cell bank and master cell bank(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological
DE_HH_01_GMP_2019_0045,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Substances(en)
NL/H 19/2014265A,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: autologous gene therapy product(en) Special Requirements               : 3  Live Cells 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
19/15508-10,
OGYÉI/26615-6/2019,
UK GMP 18807 Insp GMP 18807/1409367-0005,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
VMDGMP/M079/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Veterinary poultice and hoof pad(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Veterinary poultice and hoof pad(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
sukls256173/2019,1 NON-COMPLIANT MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Manufacture of APIs(en)
DE_HE_01_GMP_2021_0089,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA(IMP) 25224 Insp GMP/IMP 25224/616467-0015,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.1.7  Tissue engineered products 1.3.1.8  Other: Enucliated, non-replicating Human cells(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological"
DE_HE_01_GMP_2020_0025,
UK GMP 18807 Insp GMP 18807/11353-0007,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 735 Insp GMP 735/546161-0005,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA 735 Insp GMP 735/93559-0005,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_NW_05_GMP_2021_0001,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
19/15508-11,
DE_BW_01_GMP_2019_0129,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_BW_01_GMP_2020_0002,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.2  Capsules, soft shell 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_BY_05_GMP_2020_0010,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2019_0212,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2020_0004,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging
DE_HH_01_GMP_2020_0027,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
ZVA/LV/2019/018H,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
sukls327933/2019,
DE_BY_04_GMP_2024_0038,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.1.6  Other: Pre-filled parenteral syringes(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.2.5  Other: Pre-filled parenteral syringes(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UP/I-530-10/20-03/04;381-10-05/241-20-03,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: hormone - cortisone(en) 1.2.1.8  Other solid dosage forms: Granules,Pellets,Powder for oral solution and suspension,Granule for oral solution and suspension(en) 1.2.1.11  Semi-solids Special Requirements               : 7  Other: hormone - cortisone(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: hormone - cortisone(en) 1.5.1.8  Other solid dosage forms: Granules,Pellets,Powder for oral solution and suspension,Granule for oral solution and suspension(en) 1.5.1.11  Semi-solids Special Requirements               : 7  Other: hormone - cortisone(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2019_0249,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK MIA 48259 Insp GMP 48259/16988769-0005,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
DE_HE_01_GMP_2019_0251,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
2019/25698_2,
DE_HE_01_GMP_2020_0008,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionatio(en)
DE_NI_02_GMP_2019_0039,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates
DE_SH_01_GMP_2021_0005,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
NL/H 19/2014264,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
OGYÉI/22758-6/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UP/I-530-10/20-03/11; 381-13-08/243-20-03,
DE_HE_01_GMP_2019_0236,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HH_01_GMP_2021_0024,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.5  Other: Tirofiban 0.05 mg/ml solution for infusion, bag 250 ml Tirofiban 0.25 mg/ml concentrate for solution for infusion,  vial 50ml Linezolid 2 mg/ml solution for infusion, bag 300 ml(en)"
ES/127HV/20,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Manufacturing and storage of Master cell bank and/or Working cell bank(en)
UK MIA(IMP) 32390 Insp IMP 32390/18853104-0001,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Primary Labelling-not primary packaging, no open primary containers. Site of physical importation.(en) 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.2.3.7  Tissue engineered products 2.2.3.8  Other: Cell banks(en) 2.3  Other importation activities 2.3.4  Other: Primary Labelling-not primary packaging, no open primary containers. Site of physical importation.(en)"
DE_HE_01_GMP_2019_0161,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2019_0248,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2020_0011,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA 20782 Insp GMP 20782/17799871-0007,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.17  Other: Other solid dosage forms include powders and granules(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Other solid dosage forms include powders and granules(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 298 Insp GMP/GDP 298/14669-0021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Pillules and Herbal Teas(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.4.1.4  Other: Herbal tinctures and manufacture for export(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA(IMP) 20782 Insp GMP/IMP 20782/17799871-0006,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.17  Other: Other solid dosage forms include powders and granules(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Other solid dosage forms include powders and granules(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
DE_HE_01_GMP_2019_0160,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
GMP 14694 Insp GMP 14694/2017530-0006,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
19MPP059HPT01,
DE_HE_01_GMP_2019_0163,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HH_01_GMP_2020_0002,
UK MIA 29826 Insp GMP/IMP 29826/994229-0007,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products
UK MIA(IMP) 29826 Insp GMP/IMP 29826/994229-0007,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products
VMDGMP/M075/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
VMDGMP/M083/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.8  Other solid dosage forms: powders(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.8  Other solid dosage forms: powders(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0159,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2020_0010,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK API 14420 Insp GMP 14420/5065-0008,
UK GMP 14694 Insp GMP 14694/2017530-0006 [H],1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0140,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
OGYÉI/52010-13/2018,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell Special Requirements               : 7  Other: Hormones(en) 1.2.1.13  Tablets Special Requirements               : 7  Other: Hormones(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 22920 Insp GMP/GDP 22920/13075544-0004,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
170/7,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
DE_HE_01_GMP_2019_0137,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA 33846 Insp GMP 33846/12378715-0003,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.2  Non-sterile products
UK MIA(IMP) 14076 Insp IMP 14076/18890869-0003,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.3  Semi-solids 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.2  Semi-solids 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products"
UK MIA 3422 Insp GMP/GDP 3422/14887-0023,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Site of physical importation(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.2  Non-sterile products
UK ManA 3422 Insp GMP/GDP 3422/14887-0023,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
UK GMP 14694 Insp GMP 14694/1071923-0011,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids Special Requirements               : 7  Other: topicals(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 14694 Insp GMP 14694/4630235-0004,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2019_0158,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2019_0147,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK GMP 19575 Insp GMP/IMP 19575/3773410-0008 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK GMP 19575 Insp GMP/IMP 19575/3773410-0008 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
DE_HE_01_GMP_2019_0157,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
25615,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
FT081/MH/001/2019,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
106/2019/GMP,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Active substances /non sterile/(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
482964-0001,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.1.6  Other: ad 1.1.1.2: Cytotoxics/Cytostatics(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
169/4,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK MIA 20894 Insp GMP 20894/10219533-0003,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets"
UK MIA 20894 Insp GMP 20894/14038-0014,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
139/5,
DE_HE_01_GMP_2019_0154,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2020_0013,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA(IMP) 46345 Insp IMP 46345/14583918-0003,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation
VMDGMP/M068/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
ES/164/19,
UK API 8801 Insp GMP/IMP 8801/18235-0033,
UK MIA 8801 Insp GMP/IMP 8801/18235-0034,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.3  Biological medicinal products 2.2.3.1  Blood products
UK MIA(IMP) 8801 Insp GMP/IMP 8801/18235-0033,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.3  Biological medicinal products 2.2.3.1  Blood products
DE_HE_01_GMP_2019_0181,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
ES/136HV/19,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
ES/136HV/19/1,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
FT077/MH/002/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA(IMP) 47800 Insp GMP/IMP 47800/304289-0003,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: 976000101/ABS-10066 Angel Concentrated Platelet Rich Plasma Whole Blood Processing System, is a tabl(en) Special Requirements               : 7  Other: Point-of-care processing and delivery of the autologous RAPID PRP Gel.(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products Special Requirements               : 7  Other: Point-of-care processing and delivery of the autologous RAPID PRP Gel.(en) 1.3.1.6  Human or animal extracted products Special Requirements               : 7  Other: The processed autologous RAPID Biodynamic PRP Haematogel contains concentrated PRP, which is convert(en) 1.3.1.8  Other: The autologous RAPID Biodynamic PRP Haematogel biologically active dressing that will be produced at(en) Special Requirements               : 7  Other: Point-of-care processing and delivery of the autologous RAPID PRP Gel.(en) 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products Special Requirements               : 7  Other: Point-of-care processing and delivery of the autologous RAPID PRP Gel.(en) 1.3.2.6  Human or animal extracted products Special Requirements               : 7  Other: The processed autologous RAPID Biodynamic PRP Haematogel contains concentrated PRP, which is convert(en) 1.3.2.8  Other: The autologous RAPID Biodynamic PRP Haematogel biologically active dressing that will be produced at(en) Special Requirements               : 7  Other: Point-of-care processing and delivery of the autologous RAPID PRP Gel.(en)"
"UP/I-530-10/19-03/36, 381-13-08/337-21-11",1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates Special Requirements               : 7  Other: cytotoxic(en) 1.1.1.4  Small volume liquids Special Requirements               : 7  Other: cytotoxic(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids Special Requirements               : 7  Other: cytotoxic(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UP/I-530-10/19-03/36; 381-10-05/162-19-04,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: Powders for oral suspension(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: Powders for oral suspension(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
2020/HPF/PT/001,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging
DE_HE_01_GMP_2019_0126,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
IWSC.405.51.2019.ABU.1 WTC/0598_01_01/253,
VMDGMP/M070/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.8  Other solid dosage forms 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
044/2019/RO,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
20-Apr,
21-Apr,
22-Apr,
409-4/2019-7,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2019_0124,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK MIA 22443 Insp GMP 22443/114424-0005,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.2.5  Other: Radiopharmaceuticals(small volume liquids)(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.3  Moist heat 1.4.3  Other: Radiopharmaceuticals (moist heat)(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 51611 Insp GMP 34441/713702-0015,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
ES/002HV/20,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
UK MIA 44041 Insp GMP 44041/15292132-0008,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
UK API 8596 Insp GMP 8596/18052-0031,
UK MIA 36282 Insp GMP 36282/8148588-0005,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK MIA 8596 Insp GMP 8596/18052-0031,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
24542A,
30865A,
OGYÉI/376-6/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets Special Requirements               : 7  Other: including product with hormonal activity(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets Special Requirements               : 7  Other: including product with hormonal activity(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/28130-6/2019,
UP/I-530-10/19-03/37; 381-13-08/243-21-07,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Powder for solution for injection or infusion(en) Special Requirements               : 1  B-lactam Antibiotics 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2020/HPF/PT/002,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: lozenge(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
VMDGMP/M069/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.8  Other solid dosage forms 1.2.1.15  Intraruminal devices 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.8  Other solid dosage forms 1.5.1.15  Intraruminal devices 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
76/4,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products
76/5,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products
76/6,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products
OGYÉI/14563-2/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets Special Requirements               : 7  Other: including product with hormonal activity(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets Special Requirements               : 7  Other: including product with hormonal activity(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/363-6/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets Special Requirements               : 7  Other: including product with hormonal activity(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets Special Requirements               : 7  Other: including product with hormonal activity(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 3076 Insp GMP/GDP 3076/12995921-0003,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.1.9  Pressurised preparations 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.1.9  Pressurised preparations 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0109,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0105,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0120,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0190,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK GMP 43178 Insp GMP/IMP 43178/9986681-0004 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK MIA 15513 Insp GMP/GDP 15513/423417-0007,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
DE_HE_01_GMP_2019_0113,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0119,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK MIA 5170 Insp GMP 12470/19351-0012,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA(IMP) 12470 Insp IMP 12470/19351-0011,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA(IMP) 12470 Insp IMP 12470/9441-0014,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.17  Other: Unit and multi-dose non-sterile gels, collodions etc. unit and multi-dose nonsterile dosage forms for external use(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging"
DE_HE_01_GMP_2019_0121,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK GMP 36188 Insp GMP 36188/15625386-0002,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.3  Moist heat 1.4.3  Other: Depyrogenation of empty glass vials by dry heat(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 48442 Insp GMP 48442/18637903-0001,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
FT034/MH/001/2019,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: powders for injection(en) Special Requirements               : 1  B-lactam Antibiotics 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 1  B-lactam Antibiotics 1.2.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.2.1.17  Other: Powders for oral suspension(en) Special Requirements               : 1  B-lactam Antibiotics 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Powders for oral suspension(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
FT035/MH/001/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Powders (for oral solutions)(en) 1.2.1.13  Tablets 1.2.1.17  Other: Pellets(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Powders (for oral solutions)(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
LT/07H/2019,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2019_0118,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
OGYÉI/12388-5/2019,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0110,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0180,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA(IMP) 43821 Insp IMP 43821/17369571-0001,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.3  Biological medicinal products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products
OGYÉI/26510-6/2019,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
OGYÉI/29985-2/2022,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
OGYÉI/69574-1/2023,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0117,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
OGYÉI/69174-5/2018,
19MPP051NCR01,1 NON-COMPLIANT MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration Special Requirements               : 1  B-lactam Antibiotics
CY-QILU-2019/01,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Sterile API(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
NL/H 19/2012111,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 735 Insp GMP 735/93556-0009,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0130,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK MIA 11724 Insp GMP 11724/114445-0010,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation"
UK MIA 11724 Insp GMP 11724/19291-0010,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging"
UK MIA 11724 Insp GMP 11724/92242-0010,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging"
UK MIA 12845 Insp GMP 12845/31088-0012,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Labelling and packaging of Inhaled Nasal Spray(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Labelling and packaging of Inhaled Nasal Spray(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
UK MIA(IMP) 11724 Insp IMP 11724/114445-0011,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Overencapsulation(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
UK MIA(IMP) 11724 Insp IMP 11724/19291-0011,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Overencapsulation(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging"
UK MIA(IMP) 11724 Insp IMP 11724/92242-0011,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Overencapsulation(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products"
UK ManA 11724 Insp GMP/GDP/IMP 11724/114445-0009,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.4  Impregnated matrices 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.1.15  Intraruminal devices 1.5.1.16  Veterinary premixes 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical"
UK ManA 11724 Insp GMP/GDP/IMP 11724/19291-0009,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.4  Impregnated matrices 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.1.15  Intraruminal devices 1.5.1.16  Veterinary premixes 1.5.2  Secondary packaging"
UK ManA 11724 Insp GMP/IMP 11724/92242-0009,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.4  Impregnated matrices 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.1.15  Intraruminal devices 1.5.1.16  Veterinary premixes 1.5.2  Secondary packaging"
UK ManA 12845 Insp GMP 12845/31088-0012,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Labelling and packaging of Inhaled Nasal Spray(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Labelling and packaging of Inhaled Nasal Spray(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
19MPP050HPT01,
DE_HE_01_GMP_2019_0112,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0123,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
IT/GMP/E/06/2019,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK API 45848 Insp GMP 45848/14758219-0003,
UK MIA 4483 Insp GMP/GDP 4483/12332808-0005,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
VMDGMP/M063/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.8  Other solid dosage forms 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.8  Other solid dosage forms 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0115,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0116,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0139,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA 20504 Insp GMP 20504/13584-0022,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
UK MIA 41102 Insp GMP 41102/13810882-0004,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised
UK GMP 43225 Insp GMP 43225/10056105-0003,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.2  Capsules, soft shell 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2019_0114,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0245,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
NL/H 19/2012262,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Sachets(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Sachets(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2019_0191,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2019_0125,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0189,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA 24581 Insp GMP/GDP 24581/6024035-0006,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification
UK MIA 27776 Insp GMP/GDP 14756/5569-0013,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Pillules(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK ManA 27776 Insp GMP/GDP 14756/5569-0013,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Pillules(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
24545,
DE_HE_01_GMP_2019_0101,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0238,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2021_0096,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/26257-7/2019,
UK GMP 51358 Insp GMP 51358/18807657-0001,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
25582,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
19MPP049HPT01,
DE_HE_01_GMP_2019_0100,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0162,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA 18920 Insp GMP/GDP 18920/13777799-0005,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.2  Non-sterile products
UK MIA 40147 Insp GMP 40147/22318-0030,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK MIA 40739 Insp GMP 40739/22318-0031,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
UK MIA 45396 Insp GMP 45396/7702705-0001,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
VMDGMP/M066/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0164,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK API 398 Insp GMP/GDP 398/15148-0016,
UK GMP 13607 Insp GMP 13607/18637119-0002,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK GMP 14694 Insp GMP 14694/16387074-0003,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 14694 Insp GMP 14694/16387087-0003,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.9  Pressurised preparations 1.2.1.17  Other: Metered dose inhalers(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 14694 Insp GMP 14694/16387104-0003,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Nasal Spray(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 14694 Insp GMP 14694/16387119-0003,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.1.17  Other: Dry Powder Inhalers(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 398 Insp GMP/GDP 398/15148-0015,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised
152.7,
UK GMP 36045 Insp GMP 36045/1296204-0005,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.5  Gamma irradiation
UK GMP 39329 Insp GMP 39329/12813-0005,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
ES/144HV/19*,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Powder for injection(en) Special Requirements               : 1  B-lactam Antibiotics 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
ES/144HV/19*/2,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Powder for injection(en) Special Requirements               : 1  B-lactam Antibiotics 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
19MPP048HPT01,
DE_HE_01_GMP_2019_0103,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0122,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0211,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
238/1,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
482962-0001,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Humanplasma zur Fraktionierung / Human plasma for fractionation(en)
BE/GMP/2019/013,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2019_0136,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
482961-0001,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Humanplasma zur Fraktionierung / Human plasma for fractionation(en)
DE_HE_01_GMP_2019_0081,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK MIA 8731 Insp GMP/IMP 8731/18177-0020,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.4  Other: Labelling only, not handling of the product and secondary packaging or secondary packaging only.(en)"
UK MIA(IMP) 8731 Insp GMP/IMP 8731/18177-0020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.4  Other: Importation for Secondary Packaging(en)
UK GMP 40722 Insp GMP 40722/5200705-0005,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.6  Human or animal extracted products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
MT/023HM/2021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
MT/033HM/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
482963-0001,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Humanplasma zur Fraktionierung / human plasma for fractionation(en)
DE_HE_01_GMP_2019_0099,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
NL/H 2019/2012110,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
VMDGMP/M065/2019,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
19MPP046HPT01,
BE/GMP/2019/009,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging
IT/E/API/09/2019,
482960-0001,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Humanplasma zur Fraktionierung / Human plasma for fractionation(en)
UK GMP 22774 Insp GMP/IMP 22774/2062763-0008 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.4  Biological
UK GMP 22774 Insp GMP/IMP 22774/2062763-0008 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.4  Biological
UK MIA(IMP) 42551 Insp IMP 42551/11309940-0005,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Herbal products(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Powders, Granules(en) 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
482709-0003,
OGYÉI/12456-6/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.2  Capsules, soft shell 1.2.1.11  Semi-solids Special Requirements               : 7  Other: Cream and ointment(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.11  Semi-solids Special Requirements               : 7  Other: Cream and ointment(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK GMP 19756 Insp GMP 19756/12594-0011,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 11648 Insp GMP/GDP/IMP 11648/18895403-0001,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products
UK MIA(IMP) 11648 Insp GMP/GDP/IMP 11648/18895403-0001,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products
UK MIA 11648 Insp GMP/GDP 11648/464823-0018,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products
UK MIA 32606 Insp GMP/GDP 32606/428687-0007,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
UK MIA(IMP) 11648 Insp IMP 11648/464823-0017,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products
IT/E/API/08/2019 rev.1,
19MPP047HPT01,
IWPS.405.79.2019.KK.1 WTC/0395_01_01/178,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/19380-6/2019,
OGYÉI/19380-7/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: DC Granules(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: DC Granules(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 48278 Insp GMP 48278/18142099-0001,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
104/2019/GMP,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.4  Impregnated matrices 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA 35682 Insp GMP/GDP 35682/14951420-0005,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Application of dispensing labels(en) 1.5  Packaging 1.5.2  Secondary packaging
DE_HE_01_GMP_2019_0093,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0097,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK GMP 31798 Insp GMP 31798/378562-0010,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UP/I-530-10/19-03/30; 381-10-05/162-19-03,
DE_HE_01_GMP_2019_0086,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK MIA(IMP) 17328 Insp IMP 17328/10131931-0001,
UK MIA(IMP) 17328 Insp IMP 17328/18538131-0001,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
UK MIA(IMP) 17328 Insp IMP 17328/21317-0001,
UK MIA(IMP) 4757 Insp IMP 4757/15685-0034,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.1.5  Solids and implants 1.1.1.6  Other: Radiopharmaceuticals small and large volume liquids.Antibodies/other therapeutic proteins.Non live p(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.9  Pressurised preparations 1.2.1.17  Other: Solutions for inhalation/nebulisation, Radiopharmaceuticals (solids, oral solutions, solutions for i(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Packaging of dry powder nasal sprays including hGH, Dilution of oral liquid vaccines containing gene(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.4  Impregnated matrices 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.1.17  Other non-sterile medicinal products: Solutions for inhalation/nebulisation, Radiopharmaceuticals (solids, oral solutions, solutions for i(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: Radiopharmaceuticals/radionuclide generators(en)"
VMDGMP/M062/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.9  Pressurised preparations 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.9  Pressurised preparations 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
MT/029HM/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 1  B-lactam Antibiotics 1.2.1.8  Other solid dosage forms: powders for oral suspension(en) Special Requirements               : 1  B-lactam Antibiotics 1.2.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 1  B-lactam Antibiotics 1.5.1.8  Other solid dosage forms: powders for oral suspension(en) Special Requirements               : 1  B-lactam Antibiotics 1.5.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK GMP 18772 Insp GMP 18772/301330-0006 [H],1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Anaesthetic liquid for inhalation(en) 1.5  Packaging 1.5.2  Secondary packaging
UK GMP 18772 Insp GMP 18772/301330-0006 [V],1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Anaesthetic liquid for inhalation(en) 1.5  Packaging 1.5.2  Secondary packaging
DE_HE_01_GMP_2019_0085,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0096,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0098,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_RP_01_GMP_2019_0041,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Active Pharmaceutical Ingredients(en) 1.6  Quality control testing 1.6.3  Chemical/Physical
DK H 00123819,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
FT014/001/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.2  Capsules, soft shell 1.2.1.6  Liquids for internal use 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
FT15/MH/001/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: granules(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets Special Requirements               : 7  Other: including cytotoxics(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: granules(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets Special Requirements               : 7  Other: including cytotoxics(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HH_01_GMP_2019_0042,
DK API-H 00124419,
DE_HE_01_GMP_2019_0104,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
NL/H 19/2011774,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0095,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0102,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK MIA 32496 Insp GMP 32496/30433-0037,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.17  Other: Inhalation Anaesthetics(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Inhalation Anaesthetics(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.2  Non-sterile products"
UK MIA(IMP) 32496 Insp IMP 32496/14900912-0006,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.13  Tablets 1.2.1.14  Transdermal patches 1.2.1.17  Other: Unidose forms forn nasal delivery(en) 1.6  Quality control testing 1.6.3  Chemical/Physical"
UK MIA(IMP) 32496 Insp IMP 32496/30433-0039,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.13  Tablets 1.2.1.17  Other: Granules and Inhalation Anaesthetics(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Granules and Inhalation Anaesthetics(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA(IMP) 39541 Insp IMP 39541/7765098-0012,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
UK MIA(IMP) 49464 Insp IMP 49464/18321324-0003,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.17  Other: FAECAL MICROBIOTA(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.6  Human or animal extracted products 1.3.1.8  Other: FAECAL MICROBIOTA(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.17  Other non-sterile medicinal products: FAECAL MICROBIOTA(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility
UK ManA 32496 Insp GMP 32496/30433-0037,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.1.15  Intraruminal devices 1.2.1.17  Other: Inhalation Anaesthetics(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.1.15  Intraruminal devices 1.5.1.17  Other non-sterile medicinal products: INHALATION ANAESTHETICS(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.4  Other: Importation of Intermediate which undergoes further processing(en)
DE_HE_01_GMP_2019_0092,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_BY_05_GMP_2020_0020,
DE_BY_05_GMP_2019_0066,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.5  Solids and implants 1.1.3  Batch certification 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.3  Other Special Requirements              : 1  B-lactam Antibiotics 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms Special Requirements               : 1  B-lactam Antibiotics 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA 51016 Insp GMP 51016/115169-0007,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.3  Chewing gums 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.1.17  Other: Creams, pastes, ointments(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
VMDGMP/M061/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2019_0084,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0222,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2019_0080,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK MIA 1613 Insp GMP 1613/24778-0017,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 33155 Insp GMP 33155/9745791-0006,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
OGYÉI/248-7/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 20848 Insp GMP 20848/13984-0016,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
UK MIA(IMP) 3070 Insp GMP/GDP/IMP 3070/14720-0044,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
OGYEI/12423-6/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2019_0128,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
002918/06.08.02.00/2019,
101/2019/GMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powder(en) 1.2.2  Batch certification 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA 16133 Insp GMP/IMP 16133/31039-0017,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.17  Other: Specials consisting of tablets, powders and granules.(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.4  Other: Manufacture of powders, granules, dietary supplements and vitamins(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
UK MIA(IMP) 16133 Insp GMP/IMP 16133/31039-0017,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.3  Chewing gums 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.17  Other: Semi Solid and dry extracts of funghi supercritical fluid extracts. Assembly of diagnostic kits(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Enzymes, Laccase, SOD, Cytochrome, P450, Proteases derived form fungh(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.4.1.4  Other: Herbal & homeopathic products, vitamins, supplements and novel foodstuffs(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.8  Other: Enzymes, Laccase, SOD, Cytochrome, P450, Proteases derived form fungh(en) 2.3  Other importation activities 2.3.4  Other: Herbal & homeopathic products, vitamins, supplements and novel foodstuffs(en)"
199/4,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.5  Biotechnology products
DE_HE_01_GMP_2019_0127,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK GMP 29716 Insp GMP/IMP 29716/388368-0020 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological
UK GMP 29716 Insp GMP/IMP 29716/388368-0020 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological
UK GMP 52653 Insp GMP 52653/19259723-0002 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological
UK GMP 52653 Insp GMP 52653/19259723-0002 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological
UK MIA 25258 Insp GMP/GDP 25258/6353247-0006,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
DE_BY_04_GMP_2021_0059,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Granules for direct compression: Ibuprofen DC 90(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Granules for direct compression(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA(IMP) 44168 Insp IMP 44168/21915-0009,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Autologus cellular therapies for direct infusion. Allogenic cell therapies(en) 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.1.4  Gene therapy products 1.3.1.8  Other: Autologus cellular therapies using cells extracted from human tissue prior to manipulation. The fina(en) 1.3.2  Batch Certification (list of product types) 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.3.2.8  Other: Autologus cellular therapies using cells extracted from human tissue prior to manipulation. The fina(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
002917/06.08.02.00/2019,
030/2019/RO,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates Special Requirements               : 7  Other: cytostatics/cytotoxics(en) 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
19MPP036HPT02,
2019/HPF/PT/008,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: powder for oral suspension(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: powder for oral suspension(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0094,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2019_0187,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
FT073/MH/001/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.2  Capsules, soft shell 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
FT074/MH/001/2019,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IN-2-14/19/2 (API),
OGYÉI/64259-6/2018,
UP/I-530-10/19-03/27; 381-10-05/243-19-03,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
ZVA/LV/2019/020H,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: powders for solution for injection/infusion(en) Special Requirements               : 1  B-lactam Antibiotics 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IT/GMP/E/5-2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: Corticosteroids(en) 1.2.1.9  Pressurised preparations Special Requirements               : 7  Other: Corticosteroids(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: Corticosteroids(en) 1.5.1.9  Pressurised preparations Special Requirements               : 7  Other: Corticosteroids(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 22481 Insp GMP 22481/30300-0012,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA(IMP) 29724 Insp IMP 29724/18694016-0001,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0186,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA 36456 Insp GMP 36456/1523938-0007,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA(IMP) 36456 Insp IMP 36456/1523938-0008,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Orodispersible tablets, Oral Powder Blends/ Process API through Suupercritical Fluid rig to modifyit(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
UK API 10592 Insp GMP 10592/3922-0039,
UK GMP 22481 Insp GMP 22481/117371-0005,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 4296 Insp GMP/GDP 4296/15286-0025,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised
UK ManA 4296 Insp GMP/GDP 4296/15286-0025,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised
BG/GMP/2019/158,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0184,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA 3063 Insp GMP 3063/4327-0013,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
11-Jan,
42/10,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: pellets(en) 1.2.1.13  Tablets 1.2.1.17  Other: periodontal inserts(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: periodontal inserts(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
42/9,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: pellets(en) 1.2.1.13  Tablets 1.2.1.17  Other: periodontal inserts(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: periodontal inserts(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
DE_HH_01_GMP_2022_0002,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: eye drops(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
19MPP006HPT01,
DE_HE_01_GMP_2019_0198,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA(IMP) 32879 Insp GMP/GDP/IMP 32879/93706-0021,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
UK MIA 41733 Insp GMP 41733/7009117-0003,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
19MPP007HPT02,
IT/E/APIMED/03/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.4  Biological
DE_HE_01_GMP_2019_0068,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
SK/007V/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UP/I-530-10/19-03/33; 381-10-05/162-19-03,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
VMDGMP/M057/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: Powders(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
001149/06.08.02.00/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.1.17  Other: direct compression granules(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
NL/H 19/2009637,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
NL/H 19/2010946,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.17  Other: Inhalation Vapour, Liquid(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.17  Other non-sterile medicinal products: Inhalation Vapour, Liquid(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2020_0042,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
DK API-H 00122119,
UK MIA 15817 Insp GMP 15817/7147-0015,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical"
UK MIA 49445 Insp GMP 49445/18310065-0002,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
DE_HE_01_GMP_2019_0221,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
ES/165/20,
INS/GMP/2018/111; INS/GMP/2018/112; INS/GMP/2019/063 and INS/GMP/2019/064,1 NON-COMPLIANT MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Active substance(en)
UK GMP 2629 Insp GMP/IMP 2629/13862358-0004 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility
UK GMP 2629 Insp GMP/IMP 2629/13862358-0004 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility
UK GMP 46334 Insp GMP/IMP 46334/14567004-0002 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK GMP 46334 Insp GMP/IMP 46334/14567004-0002 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK GMP 46334 Insp GMP/IMP 46334/74567004-0002 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK GMP 46334 Insp GMP/IMP 46334/74567004-0002 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK MIA 34799 Insp GMP 34799/18989723-0001,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK MIA 34799 Insp GMP/GDP 34799/1051003-0013,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK API 133 Insp GMP 133/3787-0024,
UK GMP 19575 Insp GMP/IMP 19575/3773410-0007 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK MIA 133 Insp GMP/GDP 133/3787-0023,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.17  Other: Hormone Semi-Solid(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 14340 Insp GMP 14340/31133-0016,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.2  Capsules, soft shell 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.6  Quality control testing 1.6.3  Chemical/Physical"
UK MIA 52731 Insp GMP/GDP 133/3787-0025,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.17  Other: Hormone Semi-Solid(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.17  Other non-sterile medicinal products: Hormone Semi-Solid(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
6.2.1-2019-002484,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: sachets, powder in bottle for oral suspension(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: sachets, powder in bottle for oral suspension(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
IWPS.405.57.2019.KK.1 WTC/0489_01_01/127,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.6  Human or animal extracted products 1.3.2  Batch Certification (list of product types) 1.3.2.6  Human or animal extracted products 1.5  Packaging 1.5.2  Secondary packaging
OGYÉI/64262-6/2018,
UK GMP 19824 Insp GMP/IMP 19824/1721357-0021 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.1.4  Biological
UK GMP 19824 Insp GMP/IMP 19824/1721357-0021 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.1.4  Biological
UK MIA(IMP) 37245 Insp GMP/IMP 37245/14726845-0005,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation
sukls416418/2018,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.6  Quality control testing 1.6.3  Chemical/Physical
5.9.1-2019-011507,
6.2.1-2019-006289,
DE_HH_01_GMP_2019_0047,
IWPS.405.56.2019.KK.1 WTC/0492_01_01/125,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
IWPS.405.56.2019.KK.2 WTC/0492_02_01/126,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: storage(en)
OGYÉI/2724-8/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Manufacture of pellets(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Manufacture of pellets(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/69253-1/2023,
UK GMP 43178 Insp GMP/IMP 43178/9986681-0003 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK MIA 94 Insp GMP 94/18415-0029,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.3  Chemical/Physical
UK MIA(IMP) 25224 Insp GMP/IMP 25224/89442-0011,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.8  Other: Recombinant Proteins(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.8  Other: Recombinant Proteins(en)
sukls78875/2019,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
19MPP026HPT01,
DE_BE_01_GMP_2019_0020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK GMP 16776 Insp GMP/IMP 16776/8489-0015 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.4  Biological
UK GMP 16776 Insp GMP/IMP 16776/8489-0015 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.4  Biological
UK GMP 33228 Insp GMP/IMP 33228/464870-0012 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.4  Biological
UK GMP 33228 Insp GMP/IMP 33228/464870-0012 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.4  Biological
VMDGMP/M052/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
VMDGMP/T054/2019,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
20/8,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Powders (including powders of Penicillins)(en) 1.2.1.16  Veterinary premixes 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Powders (including powders of Penicillins)(en) 1.5.1.16  Veterinary premixes 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 22775 Insp GMP/IMP 22775/31008-0005 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility
UK GMP 22775 Insp GMP/IMP 22775/31008-0005 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility
UK MIA 17872 Insp GMP 17872/91400-0009,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA 25298 Insp GMP 25298/86344-0012,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK MIA 33508 Insp GMP/IMP 33508/520482-0006,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.5  Other: Combination Product - sterile Injectable Pressurised (Aerosol) Product(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Importation and testing of device components for combination product(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.3  Moist heat 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 20395 Insp GMP/GDP 20395/618199-0015,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
19MPP025HPT01,
IT/E/API/06/2019,
UK MIA 1411 Insp GMP/IMP 1411/1767214-0011,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Small volume powders.(en) 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
UK MIA 45317 Insp GMP/IMP 45317/13064076-0005,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
UK MIA(IMP) 1411 Insp GMP/IMP 1411/1767214-0011,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Powders(en) 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
UK MIA(IMP) 45317 Insp GMP/IMP 45317/13064076-0005,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
19MPP030HPT01,
2019/HPF/PT/005,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: formulated granule of acetylsalicylic acid and starch(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IT/E/API/10/2019 rev.1,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: manufacture of active substances(en)
UK MIA 289 Insp GMP 289/30305-0021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
UK MIA(IMP) 34777 Insp IMP 34777/120399-0015,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.2  Semi-solids 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.17  Other: Powders(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.3  Moist heat 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging"
482394-0007,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
UK MIA 11724 Insp GMP/IMP 11724/114445-0008,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.3.2.8  Other: Injectables, monoclonal antibodies, deactivated viruses, antigens and parenteral systemic antifungal(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.4  Impregnated matrices 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.2.3.8  Other: Injectables, monoclonal antibodies, deactivated viruses, antigens and parenteral systemic antifungal(en) 2.3  Other importation activities 2.3.1  Site of physical importation"
UK MIA 11724 Insp GMP/IMP 11724/19291-0008,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.4  Impregnated matrices 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.2  Secondary packaging"
UK MIA 11724 Insp GMP/IMP 11724/92242-0008,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.4  Impregnated matrices 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.2  Secondary packaging"
UK MIA 12063 Insp GMP 12063/2698-0021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.17  Other: Chewable Tablets, Effervescent powder, Powder for oral solution, Compressed lozenges, Powder for Ora(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing"
UK MIA 12557 Insp GMP/IMP 12557/120399-0014,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
UK MIA(IMP) 11724 Insp GMP/IMP 11724/114445-0008,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.4  Impregnated matrices 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.1.17  Other non-sterile medicinal products: Granules, Powders(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: Herbal products(en)"
UK MIA(IMP) 11724 Insp GMP/IMP 11724/19291-0008,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.4  Impregnated matrices 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.1.17  Other non-sterile medicinal products: Granules, Powders(en) 1.5.2  Secondary packaging"
UK MIA(IMP) 11724 Insp GMP/IMP 11724/92242-0008,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.4  Impregnated matrices 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products"
UK MIA(IMP) 46616 Insp IMP 46616/15002150-0003,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
VMDGMP/M055/2019,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: Powders(en) 1.5.1.16  Veterinary premixes 1.5.2  Secondary packaging
DE_HE_01_GMP_2019_0218,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK API 8170 Insp GMP 8170/17726-0006,
UK MIA 21752 Insp GMP 21752/2907930-0010,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK MIA 29595 Insp GMP/IMP 29595/10933-0013,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Liquid conjugate bulk drug substances in solution(en) Special Requirements               : 7  Other: Including cytotoxic and potent bulk drug substances(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: QP certification of the manufacturing and testing conducted on Liquid conjugate bulk drug substances(en) Special Requirements               : 7  Other: Including cytotoxic and potent bulk drug substances(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: QP certification of the manufacturing and testing conducted on Liquid conjugate bulk drug substances(en) Special Requirements               : 7  Other: Including cytotoxic and potent bulk drug substances(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA 398 Insp GMP 398/15148-0014,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised
UK MIA 8731 Insp GMP/IMP 8731/18177-0019,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.4  Other: Labelling only, not handling of the product and secondary packaging or secondary packaging only.(en)"
UK MIA(IMP) 11709 Insp GMP/IMP 11709/22528-0010,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Radiopharmaceuticals(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA(IMP) 25044 Insp GMP/IMP 25044/83804-0008,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.4  Impregnated matrices 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.7  Medicinal gases 1.2.1.8  Other solid dosage forms 1.2.1.9  Pressurised preparations 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.1.14  Transdermal patches 1.2.1.17  Other: Buccal film(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: radio-labelled products(en)"
UK MIA(IMP) 29595 Insp GMP/IMP 29595/10933-0013,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Liquid conjugate bulk drug substances in solution(en) Special Requirements               : 7  Other: Including cytotoxic and potent bulk drug substances(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: QP certification of the manufacturing and testing conducted on Liquid conjugate bulk drug substances(en) Special Requirements               : 7  Other: Including cytotoxic and potent bulk drug substances(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: QP certification of the manufacturing and testing conducted on Liquid conjugate bulk drug substances(en) Special Requirements               : 7  Other: Including cytotoxic and potent bulk drug substances(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK MIA(IMP) 8731 Insp GMP/IMP 8731/18177-0019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.4  Other: Importation for Secondary Packaging(en)
UK MIA(IMP) 8794 Insp IMP 8794/22532-0007,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.6  Human or animal extracted products 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA 12862 Insp GMP/IMP 12862/119098-0020,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.17  Other: Medicated Lozenges(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Filling of vaccines and recombinant DNA (rDNA)(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.17  Other non-sterile medicinal products: Solid non-sterile unit dosage forms: capsules. Medicated Lozenges(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
UK MIA 1839 Insp GMP/IMP 1839/119098-0022,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.17  Other: Medicated Lozenges(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.17  Other non-sterile medicinal products: Medicated Lozenges(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA(IMP) 12862 Insp GMP/IMP 12862/119098-0020,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.17  Other: Medicated Lozenges(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Filling of vaccines and recombinant DNA (rDNA)(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.17  Other non-sterile medicinal products: Solid non-sterile unit dosage forms; capsules. Medicated Lozenges(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
UK MIA(IMP) 17136 Insp GMP/IMP 17136/2431088-0006,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Cellular therapies, tissue engineered products(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.1.8  Other: Tissue Engineered Products(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
UK MIA(IMP) 17136 Insp GMP/IMP 17136/865904-0008,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Cellular Therapies, Tissue engineered Products, Radiopharmaceuticals (ie radiolabelled cell therapy(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.1.4  Gene therapy products 1.3.1.8  Other: Tissue engineered products, Radiopharmaceuticals (ie radiolabelled cell therapy product)(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Sterile cellular and tissue engineered products(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
UK MIA(IMP) 1839 Insp GMP/IMP 1839/119098-0022,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.1.6  Other: not specified(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.2.5  Other: not specified(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Vaccines, Recombinant DNA (rDNA)(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Solid non-sterile unit dosage forms - capsules(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical"
UK MIA(IMP) 63 Insp GMP/IMP 63/17092-0039,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.3  Chewing gums 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Powders(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: (1) Standardised Senna and (2) Buprenorphine Hydrochloride(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.3  Moist heat 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Powder and Granules(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
CH19-0209,1 NON-COMPLIANT MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Manufacture of Active Substances(en)
78030/27-06-2019,
UK API 18667 Insp GMP 18667/20306-0005 [H],
UK MIA 18756 Insp GMP/IMP 18756/91541-0010,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.4  Impregnated matrices 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
UK MIA 36687 Insp GMP 36687/18644887-0002,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK MIA(IMP) 16209 Insp GMP/IMP 16209/476867-0008,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.8  Other: Biological active starting materials(when required by national legislation)(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.8  Other: Biological active starting materials(when required by national legislation)(en) 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
UK MIA(IMP) 17479 Insp IMP 17479/12551187-0004,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA(IMP) 18756 Insp GMP/IMP 18756/91541-0010,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.4  Impregnated matrices 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches"
UK ManA 18756 Insp GMP/IMP 18756/91541-0010,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.4  Impregnated matrices 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.1.15  Intraruminal devices 1.5.2  Secondary packaging"
DE_BY_05_GMP_2019_0030,
DE_HE_01_GMP_2020_0081,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HH_01_GMP_2019_0052,
DE_HH_01_GMP_2023_0022,
"UP/I-530-10/19-03/25, 381-10-05/243-19-03",1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 14988 Insp GMP/IMP 14988/14391249-0003 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK GMP 14988 Insp GMP/IMP 14988/14391249-0003 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK MIA 14988 Insp GMP/IMP 14988/336740-0010,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.2.3.8  Other: This variation in support of an MA appliction for Enoxoparin which is derived from porcine sources.(en)
UK MIA(IMP) 14988 Insp GMP/IMP 14988/336740-0010,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.17  Other: Suspension nasal spray(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products"
UK MIA(IMP) 40081 Insp GMP/IMP 40081/4000415-0003,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: PET Radiotracers(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: PET Radiotracers(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK API 21540 Insp GMP 21540/606032-0006,
UK MIA 17269 Insp GMP/IMP 17269/22626-0012,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: formulated bulk product is manufactured at this site and transferred to an external contractor for s(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 33336 Insp GMP 16409/8018-0010,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
UK MIA(IMP) 17269 Insp GMP/IMP 17269/22626-0012,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.6  Human or animal extracted products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products
UK MIA(IMP) 43280 Insp GMP/IMP 43280/10139174-0003,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation
FT075/SA/001/2019,
UK API 116 Insp GMP 116/1966883-0005,
UK API 116 Insp GMP 116/2282-0005,
UK MIA 101 Insp GMP/IMP 101/1135-0018,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.4  Other: Ordering and Invoicing of all products, including those imported from outside of the EEA(en)"
UK MIA 17479 Insp GMP/IMP 17479/12357407-0004,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.3  Cell therapy products 1.3.1.4  Gene therapy products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA 17479 Insp GMP/IMP 17479/285627-0007,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.3  Cell therapy products 1.3.1.4  Gene therapy products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA 18515 Insp GMP 18515/10726794-0003,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Merional (Menotrophin BP) human menopausal gonadotrophin Fostimon (urofollitropin)(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.8  Other: Merional (Menotrophin BP) human menopausal gonadotrophin Fostimon (urofollitropin)(en)
UK MIA 4416 Insp GMP 4416/1803065-0009,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification
UK MIA 50837 Insp GMP 50837/10535096-0005,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK MIA 8215 Insp GMP 8215/1172183-0010,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
UK MIA(IMP) 101 Insp GMP/IMP 101/1135-0018,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.3.2.8  Other: Standard fermentation Biological Products(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.2.3.8  Other: Standard fermentation Biological Products(en) 2.3  Other importation activities 2.3.4  Other: The Importation of Radiopharmaceuticals/Radionuclide generators(en)
UK MIA(IMP) 17479 Insp GMP/IMP 17479/12357407-0004,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.3  Cell therapy products 1.3.1.4  Gene therapy products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA(IMP) 17479 Insp GMP/IMP 17479/285627-0007,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.3  Cell therapy products 1.3.1.4  Gene therapy products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared
UK MIA(IMP) 33496 Insp GMP/IMP 33496/20860-0008,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.17  Other: Including Oral Inhalation (Including filling primary container(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products"
UK MIA(IMP) 33496 Insp IMP 20066/20860-0009,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 7  Other: Substance with Horrmonal Activity(en) 1.2.1.17  Other: Oral Inhalation (Including filling primary container and Substance with Hormonal Activity)(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.17  Other non-sterile medicinal products: Including Oral Inhalation (Including filling primary container and Substance with Hormonal activity)(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products"
UP/I-530-10/19-03/20; 381-10-05/162-19-03,
482618-0002,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DK H 00117019,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DK V 00124019,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
OGYÉI/51228-6/2018,
UK API 10592 Insp GMP 10592/1524-0019,
UK MIA 10592 Insp GMP 10592/1524-0018,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Active intermediate Potassium Clavulanate/ Amoxicillin Trihydrate 1:1 non sterile mix, Blending of A(en) 1.6  Quality control testing 1.6.3  Chemical/Physical"
UK MIA 14 Insp GMP 14/4488-0031,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK MIA(IMP) 45848 Insp GMP/IMP 45848/7560-0023,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.1.6  Other: Radiolabelled Products & Cytotoxic Products(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.17  Other: Radiolabelled Products & Cytotoxic Products, Moulded Tablets, Drug in a Vial, Over encapsulated prod(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products"
UK MIA(IMP) 45848 Insp IMP 45848/7560-0024,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.1.6  Other: Radiolabelled Products & Cytotoxic Products(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.17  Other: Radiolabelled Products & Cytotoxic Products, Moulded Tablets, Drug in a Vial, Over encapsulated prod(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products"
229/3,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
481862-0008,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK API 322 Insp GMP/IMP 322/14798-0027,
UK MIA 1074 Insp GMP 1074/1630-0019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Products containing oils of natural origin for inhalation or topical application.(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.3  Other: Products containing oils of natural origin for inhalation or topical application.(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
UK MIA 19803 Insp GMP 19803/1424017-0007,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK MIA 322 Insp GMP/IMP 322/14798-0027,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Including Powders, Labelling of Primary containers & secondary packaging of primary containers.(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical"
UK MIA 40147 Insp GMP 40739/22318-0028,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK MIA 4483 Insp GMP 4483/12332808-0003,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK MIA 6719 Insp GMP 6719/8688292-0004,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
UK MIA(IMP) 322 Insp GMP/IMP 322/14798-0027,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.11  Semi-solids 1.5.1.17  Other non-sterile medicinal products: Pessaries, Powders(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products"
23933,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
409-2/2019-5,
UK MIA 13581 Insp GMP 13581/4097-0022,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA 42117 Insp GMP 42117/12716989-0003,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK MIA 43805 Insp GMP 43805/12930896-0003,"2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.4  Other: Site for processing purchase order, sales order(en)"
UK MIA 8794 Insp GMP 8794/114485-0010,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Viper Vet manufactured for trials in accordance with ATC(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 8794 Insp GMP 8794/22532-0009,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.6  Human or animal extracted products 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA(IMP) 13581 Insp IMP 13581/4097-0023,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.1.5  Solids and implants 1.1.1.6  Other: Dry Powders(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.5  Other: Dry Powder for off-site terminal sterilisation by irradiation(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.2  Immunological products 1.3.1.3  Cell therapy products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
UK MIA(IMP) 44168 Insp GMP/IMP 44168/21915-0006,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Autologus cellular therapies for direct infusion. Allogenic cell therapies(en) 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.1.4  Gene therapy products 1.3.1.8  Other: Autologus cellular therapies using cells extracted from human tissue prior to manipulation. The fina(en) 1.3.2  Batch Certification (list of product types) 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.3.2.8  Other: Autologus cellular therapies using cells extracted from human tissue prior to manipulation. The fina(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
UK MIA(IMP) 8794 Insp IMP 8794/114485-0008,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UP/I-530-10/19-03/14; 381-10-05/243-19-03,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
VMDGMP/M059/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.2  Batch certification
136/9,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA 1074 Insp GMP/GDP 1074/1630-0022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Products containing oils of natural origin for inhalation or topical application.(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.3  Other: Products containing oils of natural origin for inhalation or topical application.(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
UK MIA(IMP) 19124 Insp GMP/IMP 19124/92248-0007,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.2.5  Other: Implant for Injection using Glide Technologies Solid Dose Injector System;; Drug loaded, lyphilised(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.3.1.8  Other: Proteins and Biologics derived from cell lines(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Hormones, Cytotoxics/Cytostatics, Non-Cytotoxic Organic/Inorganic Chemically active.(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
ES/106HV/19*,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.5  Solids and implants Special Requirements               : 1  B-lactam Antibiotics 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 1  B-lactam Antibiotics 1.2.1.8  Other solid dosage forms Special Requirements               : 1  B-lactam Antibiotics 1.2.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 1  B-lactam Antibiotics 1.5.1.8  Other solid dosage forms Special Requirements               : 1  B-lactam Antibiotics 1.5.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2019_0050,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.4  Solids and implants 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0217,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK API 42785 Insp GMP 42785/13455310-0002,
UK MIA 14023 Insp GMP/IMP 14023/4574-0018,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.1.17  Other: Freeze dried tablet (Zydis).(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 20075 Insp GMP/IMP 20075/2813978-0004,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
UK MIA 4509 Insp GMP 4509/31333-0018,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA(IMP) 14023 Insp GMP/IMP 14023/4574-0018,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.1.17  Other: Freeze dried tablets (Zydis)(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
FT016/001/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK GMP 29980 Insp GMP 29980/310043-0006,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Of an apple flavoured Iron rich water dietary supplement.(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Iron Rich water filtered and filled into sachets for use as a dietary supplement(en) 1.5.2  Secondary packaging
VMDGMP/M048/2019,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Intermediate product- blend of pharmaceutical active ingredients(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Intermediate product- blend of pharmaceutical active ingredients(en) 1.6  Quality control testing 1.6.3  Chemical/Physical
230/3,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.1.6  Other 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.4  Other products or manufacturing activity 1.4.3  Other: Lyophilisiation of active substance of another party(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
95/9,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.2.5  Other: Radioactive products(en) 1.1.3  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.10  Radionuclide generators 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.8  Other: Radiopharmaceuticals / Radionuclide generators(en)
DE_BY_04_GMP_2021_0032,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Master Cell Bank and Working Cell Bank, Plasmides and Vectors (also viral)(en)"
DE_HE_01_GMP_2019_0223,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
BG/GMP/2019/149,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0225,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA 39395 Insp GMP 39395/17611-0007,
DE_BY_05_GMP_2019_0041,
DE_HE_01_GMP_2019_0213,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2019_0220,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK API 10336 Insp GMP/GDP 10336/1297-0011,
DE_HE_01_GMP_2019_0219,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2019_0224,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
FT010/001/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Powders(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Powders(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
INS_GMP_2018_029/ 23713,
DE_BY_05_GMP_2019_0034,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.1.17  Other: Granules (Sachets)(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Granules (Sachets)(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2019_0214,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
BE/GMP/2019/002,
DE_HE_01_GMP_2019_0129,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human plasma for fractionation(en)
UK MIA(IMP) 25224 Insp GMP/IMP 25224/119781-0022,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.5  Solids and implants 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.1.7  Tissue engineered products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biologically Active Starting materials(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA 13523 Insp GMP/GDP/IMP 13523/5566-0021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.3  Moist heat
UK MIA 8553 Insp GMP/GDP 8553/18014-0020,
UK MIA(IMP) 11149 Insp IMP 11149/122819-0007,
UK MIA(IMP) 11149 Insp IMP 11149/122819-0009,
UK MIA(IMP) 13523 Insp GMP/GDP/IMP 13523/5566-0021,
UK MIA(IMP) 14076 Insp GMP/GDP/IMP 14076/29642-0029,
UK MIA 12034 Insp GMP 12034/17846386-0002,
UK MIA 12034 Insp GMP 12034/17846386-0003,
481928-0005,
BE/GMP/2019/001,
OGYÉI/52664-6/2018,
OGYÉI/62207-2/2022,
UP/I-530-10/19-03/16; 381-10-05/162-19-03,
UP/I-530-10/19-03/16; 381-10-05/162-19-04,
481930-0005,
IWSC.405.18.2019.IPIO.1 WTC/0592_01_01/83,
UK MIA 13163 Insp GMP/GDP 13163/8515-0024,
UK MIA 427 Insp GMP/GDP/IMP 427/15276-0016,
UK MIA(IMP) 3830 Insp GMP/IMP 3830/121190-0008,
UK MIA(IMP) 427 Insp GMP/GDP/IMP 427/15276-0016,
VMDGMP/M053/2019,
DE_NW_05_GMP_2020_0001,
UK GMP 14083 Insp GMP/IMP 14083/4655-0006 [H],
UK GMP 14083 Insp GMP/IMP 14083/4655-0006 [V],
UK MIA 17780 Insp GMP/GDP 17780/41093-0016,
VMDGMP/M049/2019,
IT/E/API/07/2019,
23807,
IWSC.405.19.2019.IPIO.1 WTC/0593_01_01/85,
NL/H 19/2009632,
UK GMP 40676 Insp GMP 40676/5124258-0005 [H],
137/11,
UK API 1108 Insp GMP/GDP 1108/17762203-0002,
UK MIA 17907 Insp GMP 17907/13988-0031,
UK MIA 48152 Insp GMP/IMP 48152/16823386-0005,
UK MIA(IMP) 48152 Insp GMP/IMP 48152/16823386-0005,
ES/065/20,
2019/HPF/PT/004,
FI006/001/2019,
IT/GMP/E/03/2019,
UK MIA 15764 Insp GMP/GDP 15764/38652-0011,
UP/I-530-10/19-03/19; 381-10-05/241-19-03,
47/5,
47/6,
VMDGMP/T056/2019,
DE_BY_04_GMP_2021_0024,
UK MIA 14017 Insp GMP/GDP 14017/2776204-0007,
VMDGMP/M060/2019,
UK API 48727 Insp GMP/GDP 48727/17652846-0002 [H],
UK API 48727 Insp GMP/GDP 48727/17652846-0002 [V],
UK MIA 189 Insp GMP/GDP 189/11483-0019,
UK MIA 735 Insp GMP 735/17560-0013,
OGYÉI/67994-6/2018,
UK MIA 18693 Insp GMP/IMP 18693/11204-0015,
UK MIA 4 Insp GMP/IMP 4/15159-0027,
UK MIA 4 Insp GMP/IMP 4/3848-0037,
UK MIA(IMP) 101 Insp GMP/IMP 101/19062596-0005,
UK MIA(IMP) 18693 Insp GMP/GDP/IMP 18693/11485563-0003,
UK MIA(IMP) 18693 Insp GMP/IMP 18693/11204-0015,
UK MIA(IMP) 4 Insp GMP/IMP 4/15159-0027,
UK MIA(IMP) 4 Insp GMP/IMP 4/3848-0037,
FT020/MH/001/2021,
FT020/SA/001/2021,
IT/GMP/E/02/2019,
IWPS.405.34.2019.KKW.1 WTC/0589_01_01/60,
97/2019/GMP,
DE_BY_04_GMP_2019_0015,
NL/H 19/2009631A,
OGYÉI/57724-6/2018,
OGYÉI/66790-1/2023,
UK MIA(IMP) 11149 Insp GMP/IMP 11149/375726-0019,
DE_BY_05_GMP_2022_0076,
UK MIA 18799 Insp GMP 18799/303632-0031,
UK MIA 5977 Insp GMP 5977/16822-0021,
UK MIA 16300 Insp GMP 16331/93872-0005,
UK MIA(IMP) 3473 Insp IMP 3473/15150390-0006,
2019/HPF/PT/003,
OGYÉI/14525-6/2018,
OGYÉI/34856-7/2018,
OGYÉI/51335-2/2020,
DE_HH_01_GMP_2019_0026,
MT/038HM/2019,
NL/H 19/2009630,
UP/I-530-10/19-03/15; 381-10-05/162-19-03,
14/6,
227/3,
NL/H 18/2008858,
UK GMP 8913 Insp GMP 8913/378537-0009,
UK MIA 49794 Insp GMP 49794/18418729-0002,
DE_BY_05_GMP_2019_0016,
UK MIA 34771 Insp GMP 34771/10522896-0005,
UK MIA 18980 Insp GMP 18980/20470-0009,
UK MIA 18980 Insp GMP/GDP 19424/20470-0008,
UK MIA 19424 Insp GMP/GDP 19424/20470-0008,
UK MIA 5170 Insp GMP 5170/16108-0014,
VMDGMP/M043/2019,
UK GMP 8913 Insp GMP 8913/12228-0008,
FT071/S1/MH/001/2019,
UK MIA 19488 Insp GMP/GDP 8747/18194-0015,
UP/I-530-10/19-03/10; 381-10-05/243-19-03,
OGYÉI/37053-6/2018,
UP/I-530-10/19-03/08; 381-10-05/162-19-03,
NL/H 18/2008857,
NL/H 18/2008857 V2,
UK MIA 27794 Insp GMP/GDP 27794/1317-0029,
UK MIA 41203 Insp GMP 41203/6178293-0003,
UK ManA 41203 Insp GMP 41203/6178293-0003,
020/2019/RO,
147/5,
UK MIA 33363 Insp GMP 33363/21874-0003,
UK GMP 20100 Insp GMP 20100/594092-0006,
UK GMP 35673 Insp GMP 35673/2039030-0006,
UK GMP 46325 Insp GMP 46325/14552271-0002,
UK GMP 48961 Insp GMP 48961/18025593-0001,
UK GMP 6268 Insp GMP 6268/1704972-0014,
UK MIA 32169 Insp GMP/IMP 32169/1562-0022,
UK MIA 42760 Insp GMP 42760/9100985-0006,
UK MIA(IMP) 32169 Insp GMP/IMP 32169/1562-0022,
OGYÉI/52012-6/2018,
DE_HH_01_GMP_2019_0009,
IT/E/API/04/2019 Rev.1,
IWPS.405.24.2019.KKW.1 WTC/0587_01_01/43,
IWSC.405.7.2019.IPIO.1  WTC/0587_01_02/46,
19/005114,
19/228392,
482760-0001,
UK MIA 4556 Insp GMP 4556/31335-0008,
UK MIA 4556 Insp GMP 4556/92400-0029,
UK MIA(IMP) 10284 Insp IMP 10284/18457585-0005,
18MPP098HPT01,
IWPS.405.19.2019.KKW.1 WTC/0585_01_01/33,
UP/I-530-10/19-03/01; 381-10-05/162-19-03,
UP/I-530-10/19-03/13; 381-10-05/243-19-03,
18MPP039HPT01,
BE/GMP/2018/040,
DE_HH_01_GMP_2023_0013,
IWPS.405.20.2019.KKW.1 WTC/0586_01_01/34,
IWPS.405.20.2019.KKW.2 WTC/0586_02_01/35,
IWPS.405.20.2019.KKW.3 WTC/0586_03_01/36,
UK GMP 43109 Insp GMP 43109/9942147-0008,
UK API 32496 Insp GMP 32496/30433-0030,
UK MIA 17340 Insp GMP/GDP 17340/116084-0014,
UK MIA 6183 Insp GMP 6183/22324-0009,
7-Mar,
UK GMP 46468 Insp GMP/IMP 46468/17556174-0004 [H],
UK GMP 46468 Insp GMP/IMP 46468/17556174-0004 [V],
UK GMP 46468 Insp GMP/IMP 46468/17556174-0005 [H],
UK GMP 46468 Insp GMP/IMP 46468/17556174-0005 [V],
UK MIA 32301 Insp GMP/GDP/IMP 32301/726219-0008,
UK MIA 42551 Insp GMP 42551/11309940-0006,
UK MIA 42551 Insp GMP/IMP 42551/18615369-0001,
UK MIA(IMP) 32301 Insp GMP/GDP/IMP 32301/726219-0008,
UK MIA(IMP) 42551 Insp GMP/GDP/IMP 42551/9284660-0007,
UK MIA(IMP) 42551 Insp GMP/IMP 42551/18615369-0001,
ES/125/19,
UK API 34369 Insp GMP 34369/18372677-0001,
UK GMP 31450 Insp GMP 31450/360311-0010,
UK GMP 31450 Insp GMP 31450/360311-0012,
UK GMP 32340 Insp GMP 32340/409199-0007,
409-6/2018-5,
/ES/049HVI/19*,
006480/06.08.02.00/2018,
ES/038HVI/19,
ES/049HVI/19**,
ES/049HVI/19b,
OGYÉI/42087-6/2018,
34/6,
409-9/2018-7,
409-9/2018-8,
UK GMP 18747 Insp GMP/IMP 18747/17314655-0004 [H],
UK GMP 18747 Insp GMP/IMP 18747/17314655-0004 [V],
HPRA25287/ INS-GMP-2017-097,
NL/H 18/2008856A,
UK MIA 43900 Insp GMP 43900/18287763-0002,
UK MIA 35533 Insp GMP/GDP 35533/14984269-0003,
UK MIA 6180 Insp GMP 6180/88968-0010,
UK MIA 6180 Insp GMP 6180/88968-0011,
UK MIA(IMP) 49934 Insp IMP 49934/18458731-0001,
VMDGMP/M042/2019,
18MPP072HPT01,
UK API 40699 Insp GMP 40699/18353863-0001,
UK API 40699 Insp GMP 40699/7634946-0006,
UK GMP 40699 Insp GMP 40699/7634946-0007 [H],
UK GMP 40699 Insp GMP 40699/7634946-0007 [V],
UK MIA 6180 Insp GMP/IMP 8193/17744-0019,
UK MIA(IMP) 6180 Insp GMP/IMP 6180/17744-0018,
UK MIA(IMP) 6180 Insp GMP/IMP 8193/17744-0019,
UK GMP 6268 Insp GMP 6268/1949248-0006,
UK MIA 15134 Insp GMP/IMP 15134/31141-0016,
UK MIA 18480 Insp GMP 18480/10934-0015,
UK MIA 34424 Insp GMP/GDP 34424/708473-0010,
UK MIA 6180 Insp GMP/IMP 6180/17741-0016,
UK MIA(IMP) 15134 Insp GMP/IMP 15134/31141-0016,
UK MIA(IMP) 18480 Insp IMP 18480/10934-0014,
UK MIA(IMP) 6180 Insp GMP/IMP 6180/17741-0016,
DE_BY_04_GMP_2019_0064,
18MPP073HPT01,
IT/E/API/02/2019,
BG/GMP/2019/143,
DK H 00112719,
DK H 00114819,
UK MIA 4515 Insp GMP 4515/10848090-0002,
MT/003/HM/2019,
UK MIA 17087 Insp GMP/GDP/IMP 17087/13114-0005,
UK MIA 17087 Insp GMP/GDP/IMP 17087/30671-0030,
UK MIA(IMP) 17087 Insp GMP/GDP/IMP 17087/13114-0005,
UK MIA(IMP) 17087 Insp GMP/GDP/IMP 17087/30671-0030,
DE_HH_01_GMP_2019_0010,
62/4,
18MPP079NCR01,
IT/NCR/API/3/2018,
UK API 19108 Insp GMP 19108/29211-0006,
UK MIA 43252 Insp GMP 43252/17190-0033,
UK MIA 6464 Insp GMP 6464/17190-0032,
UK MIA 6464 Insp GMP 6464/2814220-0011,
18MPP078HPT01,
FT064/MH/001/2020,
FT064/S1/MH/001/2019,
IT/E/API/01/2019,
IT/GMP/E/01-2019,
IWPS.405.8.2019.ER.1 WTC/0462_01_01/17,
VMDGMP/M047/2019,
DE_BW_01_GMP_2019_0036,
UK GMP 22674 Insp GMP 22674/30580-0007,
UK MIA 4543 Insp GMP/IMP 4543/15498-0047,
UK MIA(IMP) 4543 Insp GMP/IMP 4543/15498-0047,
DE_HE_01_GMP_2018_0126,
UK GMP 39630 Insp GMP/IMP 39630/2968688-0005 [H],
UK GMP 39630 Insp GMP/IMP 39630/2968688-0005 [V],
UK MIA(IMP) 36699 Insp IMP 36699/17763348-0004,
UK GMP 22674 Insp GMP 22674/12043312-0002,
UK GMP 22674 Insp GMP 22674/8092057-0003,
BE/GMP/2018/039,
DE_BY_04_GMP_2018_0130,
VMDGMP/M044/2018,
DE_HE_01_GMP_2019_0002,
DE_HH_01_GMP_2019_0013,
UK GMP 19756 Insp GMP 19756/617558-0006 [H],
UK GMP 19756 Insp GMP 19756/617558-0006 [V],
UP/I-530-10/19-03/06; 381-10-05/162-19-03,
482576-0002,
UK GMP 20416 Insp GMP 19756/18560365-0003,
UK GMP 22882 Insp GMP 22882/646723-0006,
UK GMP 44338 Insp GMP 44338/11868716-0002,
UK MIA(IMP) 12155 Insp GMP/IMP 12155/29634-0013,
UK MIA(IMP) 16993 Insp IMP 16993/29634-0014,
ZVA/LV/2019/004H,
OGYÉI/35652-6/2018,
OGYÉI/62207-3/2022,
LT/06H/2018,
OGYÉI/34057-6/2018,
OGYÉI/34057-8/2018,
OGYÉI/69577-1/2023,
UK MIA(IMP) 42803 Insp GMP/IMP 42803/11098517-0005,
UK GMP 22572 Insp GMP/IMP 22572/93666-0008 [H],
UK GMP 22572 Insp GMP/IMP 22572/93666-0008 [V],
UK MIA 13079 Insp GMP/GDP/IMP 13079/11009752-0011,
UK MIA(IMP) 13079 Insp GMP/GDP/IMP 13079/11009752-0011,
UK MIA(IMP) 29724 Insp GMP/IMP 18739/114966-0006,
DK API-H 00110918,
2019/HPF/PT/002,
BE/GMP/2018/038,
